Changes to Russian e-cigarette regulations questioned

Apr.18.2023
Changes to Russian e-cigarette regulations questioned
CRPT, the operator of the "honest label" system, confirms no changes to their system due to e-cigarette additives ban in Russia.

On April 17th, in response to the "ban on e-cigarette additives," 2FIRSTS Moscow News Center interviewed Yuri Babinkov, the manager of the tobacco department of the "Honest Label" operation company, about the potential impact of changes to related regulatory legislation on the existing "Honest Label" system.


Yuri Babinkov | Image Source: 2FIRSTS


According to Yuri Babinkov, the manager of the tobacco department at the CRPT, ...


There will be no changes to the "honest labeling" requirements, as electronic cigarettes will be subject to mandatory labeling restrictions.


However, he stated that due to the fact that ЦРПТ company is affiliated with the state, he is unable to answer any further questions regarding trade.


According to reports, CRPT Company is the fully authorized operator of the "Honest Label" system in Russia, and is a state-owned enterprise of the Russian Federation. On November 30, 2022, the revised version of the Russian Federation's Product Circulation Control Act No. 2178 will come into effect, which mandates the use of a tracking system for "tobacco and nicotine-containing products, as well as nicotine-free products." Failure to operate such products with traceability labels will result in penalties under the Russian Federation's Administrative Violations Code and Criminal Code, depending on the severity of the offense.


Honest Label" is a Russian product tracking system that currently covers more than a dozen categories, including tobacco, food, drugs, tires, and textiles. The system was launched in 2018 and has been effective in regulating product quality. On December 15th, 2022, e-cigarettes containing nicotine oil were included in the "Honest Label" regulation.


Related Reading:


Russian nicotine product producers must apply for a license" - This bill has passed its first reading.


In One Day, Russian Flavor Ban Timeline and Background Sketch Passes Three Readings Through Bill


Russian Ban on E-Cigarette Flavorings to Take Effect on September 1; Full Proposal Attached. On April 11, Russia Will Hold First Discussion on Proposal to Ban Flavored E-Cigarettes.


Russia proposes a maximum fine of 500,000 rubles for selling electronic cigarettes to minors.


What is the progress of the ban on certain flavors in Russia's legislative process? Here is an overview of the legislative process in Russia.


Interview with Russian producer of nicotine products: The trend towards regulatory compliance is irreversible, and a complete ban on e-cigarettes is unlikely.


Expert Analysis Series:


Expert interpretation 1: Russia's ban on flavored e-cigarettes extends to all products, and specific standards for additives are yet to be disclosed.


Expert Analysis 2: Russia Sets Minimum Retail Price for E-Cigarette Products to Reduce Demand for Nicotine-Based Products.


Expert interpretation 3: Russia proposes to ban the online sale and offline display of electronic cigarettes, effective June 1.


Topic: Progress and Expert Analysis on Russia's Ban on E-Cigarette Flavors (click the image below to go to the article)



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10